BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 18400180)

  • 1. Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complex.
    Ngo JC; Huang M; Roth DA; Furie BC; Furie B
    Structure; 2008 Apr; 16(4):597-606. PubMed ID: 18400180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Region of factor IXa protease domain that interacts with factor VIIIa: analysis of select hemophilia B mutants.
    Bajaj SP
    Thromb Haemost; 1999 Aug; 82(2):218-25. PubMed ID: 10605707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the C2 domain of human factor VIII at 1.5 A resolution.
    Pratt KP; Shen BW; Takeshima K; Davie EW; Fujikawa K; Stoddard BL
    Nature; 1999 Nov; 402(6760):439-42. PubMed ID: 10586887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unsaturated phospholipid acyl chains are required to constitute membrane binding sites for factor VIII.
    Gilbert GE; Arena AA
    Biochemistry; 1998 Sep; 37(39):13526-35. PubMed ID: 9753438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIII-factor IX interactions: molecular sites involved in enzyme-cofactor complex assembly.
    Mertens K; Celie PH; Kolkman JA; Lenting PJ
    Thromb Haemost; 1999 Aug; 82(2):209-17. PubMed ID: 10605706
    [No Abstract]   [Full Text] [Related]  

  • 6. Mutating factor VIII: lessons from structure to function.
    Fay PJ; Jenkins PV
    Blood Rev; 2005 Jan; 19(1):15-27. PubMed ID: 15572214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of factor VIII in the activation of human blood coagulation factor X by activated factor IX.
    Mertens K; van Wijngaarden A; Bertina RM
    Thromb Haemost; 1985 Oct; 54(3):654-60. PubMed ID: 3937263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regions 301-303 and 333-339 in the catalytic domain of blood coagulation factor IX are factor VIII-interactive sites involved in stimulation of enzyme activity.
    Kolkman JA; Lenting PJ; Mertens K
    Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):217-21. PubMed ID: 10191249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of factor IXa and factor VIIIa interactive sites.
    O'Brien LM; Medved LV; Fay PJ
    J Biol Chem; 1995 Nov; 270(45):27087-92. PubMed ID: 7592960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural investigation of the A domains of human blood coagulation factor V by molecular modeling.
    Villoutreix BO; Dahlbäck B
    Protein Sci; 1998 Jun; 7(6):1317-25. PubMed ID: 9655335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protein structure and effect of factor VIII.
    Fang H; Wang L; Wang H
    Thromb Res; 2007; 119(1):1-13. PubMed ID: 16487577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structures of the membrane-binding C2 domain of human coagulation factor V.
    Macedo-Ribeiro S; Bode W; Huber R; Quinn-Allen MA; Kim SW; Ortel TL; Bourenkov GP; Bartunik HD; Stubbs MT; Kane WH; Fuentes-Prior P
    Nature; 1999 Nov; 402(6760):434-9. PubMed ID: 10586886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and function of the factor VIII gene and protein.
    Thompson AR
    Semin Thromb Hemost; 2003 Feb; 29(1):11-22. PubMed ID: 12640560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic interactions of factor IXa with human factor VIII and factor VIIIa.
    Lamphear BJ; Fay PJ
    Blood; 1992 Dec; 80(12):3120-6. PubMed ID: 1467518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Na+ site in blood coagulation factor IXa: effect on catalysis and factor VIIIa binding.
    Schmidt AE; Stewart JE; Mathur A; Krishnaswamy S; Bajaj SP
    J Mol Biol; 2005 Jul; 350(1):78-91. PubMed ID: 15913649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial activation of the factor VIIIa-factor IXa enzyme complex by dihexanoic phosphatidylserine at submicellar concentrations.
    Gilbert GE; Arena AA
    Biochemistry; 1997 Sep; 36(35):10768-76. PubMed ID: 9271508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin inhibits the intrinsic tenase complex by interacting with an exosite on factor IXa.
    Sheehan JP; Kobbervig CE; Kirkpatrick HM
    Biochemistry; 2003 Sep; 42(38):11316-25. PubMed ID: 14503882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase.
    Jenkins PV; Dill JL; Zhou Q; Fay PJ
    Biochemistry; 2004 May; 43(17):5094-101. PubMed ID: 15109268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cleavage of factor VIII light chain is required for maximal generation of factor VIIIa activity.
    Regan LM; Fay PJ
    J Biol Chem; 1995 Apr; 270(15):8546-52. PubMed ID: 7721754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein S down-regulates factor Xase activity independent of activated protein C: specific binding of factor VIII(a) to protein S inhibits interactions with factor IXa.
    Takeyama M; Nogami K; Saenko EL; Soeda T; Nishiya K; Ogiwara K; Yoshioka A; Shima M
    Br J Haematol; 2008 Nov; 143(3):409-20. PubMed ID: 18759761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.